Literature DB >> 12780692

Specific lytic activity against mycobacterial antigens is inversely correlated with the severity of tuberculosis.

S S De La Barrera1, M Finiasz, A Frias, M Alemán, P Barrionuevo, S Fink, M C Franco, E Abbate, M del C Sasiain.   

Abstract

The ability of peripheral blood mononuclear cells (PBMC) from patients with active tuberculosis to display cytotoxic responses against autologous Mycobacterium tuberculosis (Mtb)-pulsed macrophages was evaluated. Non-MHC restricted cell-dependent lytic activity was observed in ex vivo effector cells from tuberculosis patients and was mediated mainly by CD3(+)gammadelta TCR(+) T (gammadelta T) cells bearing CD56 and/or CD16 molecules. MHC-restricted and non-MHC restricted cytotoxic T cells (CTL) were differentially expanded upon stimulation with Mtb in tuberculosis patients and normal controls (N). Class-I restricted CD8(+) CTL and class-II restricted CD4(+) CTL were generated in PPD(+)N and to a lesser extent in PPD(-)N. Mtb-stimulated effector cells from tuberculosis patients became progressively non-MHC restricted CD4(-)CD8(-)gammadelta T cells, while lytic activity of CD4(+) and CD8(+)CTL decreased gradually as the disease became more severe. On the other hand, target cells were lysed by ex vivo cells from tuberculosis patients through the Fas-FasL and perforin pathways. Mtb-induced CD4(+) CTL from tuberculosis patients and N controls preferentially employed the Fas-FasL mechanism. Mtb-induced CD8(+) CTL effector cells from patients used the perforin-based mechanism while cells from N controls also used the Fas-FasL pathway. While Mtb-induced gammadelta CTL from patients and PPD(-)N employed the latter mechanism cells from PPD(+)N individuals also used the perforin pathway. It can be concluded that shifts in the CTL response and the cytolytic mechanisms take place as the pulmonary involvement becomes more severe.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12780692      PMCID: PMC1808720          DOI: 10.1046/j.1365-2249.2003.02176.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  41 in total

1.  Increased proportions of peripheral blood gamma delta T cells in patients with pulmonary tuberculosis.

Authors:  M Ito; N Kojiro; T Ikeda; T Ito; J Funada; T Kokubu
Journal:  Chest       Date:  1992-07       Impact factor: 9.410

2.  T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens.

Authors:  I M Orme; E S Miller; A D Roberts; S K Furney; J P Griffin; K M Dobos; D Chi; B Rivoire; P J Brennan
Journal:  J Immunol       Date:  1992-01-01       Impact factor: 5.422

3.  Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.

Authors:  D Kägi; F Vignaux; B Ledermann; K Bürki; V Depraetere; S Nagata; H Hengartner; P Golstein
Journal:  Science       Date:  1994-07-22       Impact factor: 47.728

4.  Specific lysis of mycobacterial antigen-bearing macrophages by class II MHC-restricted polyclonal T cell lines in healthy donors or patients with tuberculosis.

Authors:  D S Kumararatne; A S Pithie; P Drysdale; J S Gaston; R Kiessling; P B Iles; C J Ellis; J Innes; R Wise
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

5.  Heterogeneity of the repertoire of T cells of tuberculosis patients and healthy contacts to Mycobacterium tuberculosis antigens separated by high-resolution techniques.

Authors:  B Schoel; H Gulle; S H Kaufmann
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

6.  Gamma delta T lymphocytes in human tuberculosis.

Authors:  P F Barnes; C L Grisso; J S Abrams; H Band; T H Rea; R L Modlin
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226

7.  Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; M M Goldstein; K J Triebold; B Koller; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

8.  Lysis of human macrophages by cytolytic CD4+ T cells fails to affect survival of intracellular Mycobacterium bovis-bacille Calmette-Guérin (BCG).

Authors:  N Fazal; D A Lammas; M Rahelu; A D Pithie; J S Gaston; D S Kumararatne
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

9.  Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands.

Authors:  P Constant; F Davodeau; M A Peyrat; Y Poquet; G Puzo; M Bonneville; J J Fournié
Journal:  Science       Date:  1994-04-08       Impact factor: 47.728

10.  Expression of perforin and serine esterases by human gamma/delta T cells.

Authors:  H Koizumi; C C Liu; L M Zheng; S V Joag; N K Bayne; J Holoshitz; J D Young
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

View more
  13 in total

1.  Diagnosis of gastrointestinal tuberculosis: Using cytomorphological, microbiological, immunological and molecular techniques - A study from Central India.

Authors:  Pradyumna Kumar Mishra; A Bhargava; R P Punde; N Pathak; P Desikan; A Jain; S Varshney; K K Maudar
Journal:  Indian J Clin Biochem       Date:  2010-05-27

2.  CD3 expression distinguishes two gammadeltaT cell receptor subsets with different phenotype and effector function in tuberculous pleurisy.

Authors:  N Yokobori; P Schierloh; L Geffner; L Balboa; M Romero; R Musella; J Castagnino; G De Stéfano; M Alemán; S de la Barrera; E Abbate; M C Sasiain
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

3.  Rhodococcus equi-specific cytotoxic T lymphocytes in immune horses and development in asymptomatic foals.

Authors:  Kristin M Patton; Travis C McGuire; Melissa T Hines; Robert H Mealey; Stephen A Hines
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

4.  Rhodococcus equi-infected macrophages are recognized and killed by CD8+ T lymphocytes in a major histocompatibility complex class I-unrestricted fashion.

Authors:  Kristin M Patton; Travis C McGuire; Darrilyn G Fraser; Stephen A Hines
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

Review 5.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Authors:  Joshua S M Woodworth; Samuel M Behar
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

Review 6.  Nonclassical T cells and their antigens in tuberculosis.

Authors:  Gennaro De Libero; Amit Singhal; Marco Lepore; Lucia Mori
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-24       Impact factor: 6.915

7.  IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients.

Authors:  S de la Barrera; M Aleman; R Musella; P Schierloh; V Pasquinelli; V Garcia; E Abbate; M del C Sasiain
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

8.  Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis.

Authors:  Jan Andersson; Arina Samarina; Joshua Fink; Sayma Rahman; Susanna Grundström
Journal:  Infect Immun       Date:  2007-07-30       Impact factor: 3.441

9.  CD4(+) CD25(high) forkhead box protein 3(+) regulatory T lymphocytes suppress interferon-γ and CD107 expression in CD4(+) and CD8(+) T cells from tuberculous pleural effusions.

Authors:  L Geffner; J I Basile; N Yokobori; C Sabio Y García; R Musella; J Castagnino; M C Sasiain; S de la Barrera
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

10.  Patients with multidrug-resistant tuberculosis display impaired Th1 responses and enhanced regulatory T-cell levels in response to an outbreak of multidrug-resistant Mycobacterium tuberculosis M and Ra strains.

Authors:  Laura Geffner; Noemí Yokobori; Juan Basile; Pablo Schierloh; Luciana Balboa; María Mercedes Romero; Viviana Ritacco; Marisa Vescovo; Pablo González Montaner; Beatriz Lopez; Lucía Barrera; Mercedes Alemán; Eduardo Abatte; María C Sasiain; Silvia de la Barrera
Journal:  Infect Immun       Date:  2009-08-31       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.